Zynerba Pharmeceuticals, Inc. — Form D
Zynerba Pharmeceuticals, Inc. of Radnor, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-09. The offering totals $13.0M, of which $7.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-10-09
- Form: D
- Accession: 0001621443-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $7.3M
- Remaining: $5.7M
- Investors: 30
- Date of first sale: 2014-09-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-226158
Issuer
- Name: Zynerba Pharmeceuticals, Inc.
- CIK: 0001621443
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 170 N. Radnor-Chester Road, Radnor, PA, 19087
- Phone: 610-263-0163
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Armando Anindo | Director | Radnor, PA |
| Steven Gailar | Director | Radnor, PA |
| Philip Wagenheim | Director | Austin, TX |
| Armando Anindo | Executive Officer | Radnor, PA |
| Suzanne B Hanlon | Executive Officer | Radnor, PA |
| Terri B Sebree | Executive Officer | Radnor, PA |
More